Effects of the antiparkinsonian drug budipine on central neurotransmitter systems

Author： Klockgether T.   Wullner U.   Steinbach J.P.   Petersen V.   Turski L.   Loschmann P.-A.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.301, Iss.1, 1996-04, pp. : 67-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiparkinsonian Agents: Clinically Significant Drug Interactions and Adverse Effects, and Their Management

By Dalvi A.   Ford B.  

CNS Drugs, Vol. 9, Iss. 4, 1998-04 ,pp. : 291-310

Adis International

Access to resources Recommend Favorite

Effects of vinconate on neurotransmitter receptor systems in aged rat brain

By Araki T.   Kato H.   Shuto K.   Fujiwara T.   Itoyama Y.  

Environmental Toxicology and Pharmacology, Vol. 2, Iss. 4, 1996-12 ,pp. : 343-349

Elsevier

Access to resources Recommend Favorite

Effects of Tandospirone on Second Messenger Systems and Neurotransmitter Release in the Rat Brain

By Tanaka H.   Tatsuno T.   Shimizu H.   Hirose A.   Kumasaka Y.   Nakamura M.  

General Pharmacology, Vol. 26, Iss. 8, 1995-12 ,pp. : 1765-1772

Elsevier

Access to resources Recommend Favorite

Chronic Paroxetine Treatment: Effects on Other Non-Serotonergic Neurotransmitter Systems

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1226-1232

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of antiparkinsonian drug treatment: a systematic review

By Arbouw Maurits EL   van Vugt Jeroen PP   Egberts Toine CG   Guchelaar Henk-Jan  

Pharmacogenomics, Vol. 8, Iss. 2, 2007-02 ,pp. : 159-176

Future Medicine

Access to resources Recommend Favorite